SHARE: +/-: 0.10 SEK / Bid: 10.85 SEK / Ask: 11.30 SEK / Price: 11.30 SEK / High: 11.50 SEK / Low: 11.20 SEK / Quantity: 3 653 / Turnover: 41 609 SEK / 2019-09-23 15:28 (CEST)
Business Development
Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.
We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.
For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se
Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment
Copyright
© 2016 Spago Nanomedical AB.
All rights reserved
Address
Scheelevägen 22
SE-223 63 Lund, Sweden
